Fibroepithelioma of Pinkus

LAST UPDATED: Nov 22, 2021

Introduction

Fibroepithelioma of Pinkus was first described by Hermann Pinkus in 1953 as a rare, premalignant fibroepithelial tumour. Pinkus observed that some of the lesions had a peculiar histologic appearance that resembled both a reticulated seborrhoeic keratosis and a basal cell carcinoma (BCC). Pinkus thus considered the tumour to be a variant of basal cell carcinoma, which illustrated the interaction and interdependence of stromal and epithelial components of basal cell carcinoma.

Lesions are often diagnosed retrospectively, mostly commonly being mistaken clinically for a skin tag.

This chapter is set out as follows:


History

  • More common in patients with skin types 1 and 2
  • Affects men and women equally
  • Usually develops in people aged 40-60, but can arise at any age
  • Grow slowly 

Clinical findings

Distribution

  • Usually solitary
  • The lower trunk (especially the lower back) is the most common site although it is not limited to this region and may develop on other body sites, including the extremities, abdomen, head, and genitalia
  • It also presents more frequently in areas of radiation-damaged skin

Morphology

  • A pink to flesh-coloured (occasionally slightly brown-grey), well-demarcated plaque
  • Infrequently may be pedunculated, polypoid, or ulcerated
  • The tumour can present alone or with associated features of a seborrhoeic keratosis and / or basal cell carcinoma

Dermoscopic features

  • One paper examining the dermoscopic features of 10 such lesions found fine arborising vessels, either alone or associated with dotted vessels, and short white lines (in 100%, 70%, and 90% of lesions, respectively). Other reports have also remarked on small irregularly shaped and distributed linear vessels. It is important to note that short white lines are not very specific and can be found in a number of benign and malignant lesions      

Clinical Images

Please refer to notes on image rights at bottom of the page with regards to individual image ownership.


Management

  • Treatment is primarily surgical - lesions tend to be excised for diagnostic purposes 
  • If a BCC is present the lesion must be completely excised with a 4 mm margin of normal surrounding skin

Disclaimer - the author PCDS cannot accept responsibility for any misleading or incorrect statements, and the management of individual patients remains the direct responsibility of the individual doctor. We do however hope that visitors to this site can contact us regarding comments that are considered misleading or incorrect so that we can continue to improve the site.

Image Rights - The PCDS would like to thank Dermatoweb, DermQuest (Galderma), and others who have contributed images. All named individuals and organisations maintain copyright for the relevant images.

Quick Links

The following pharmaceutical companies have had no involvement in the content of this website or in our conference programmes

Almirall
Galderma
Glenmark
Johnson & Johnson
La Roche-Posay
LEO Pharma
Pierre Fabre
Schuco